
VBI Vaccines (VBIV) Earnings Dates & Reports
VBI Vaccines (VBIV) Most Recent Earnings
Report DateMay 15, 2024
Period EndingQ1 2024
Est. EPS-$0.53
Actual EPS-$0.55
EarningsMiss
VBI Vaccines (VBIV) Earnings
View the latest VBI Vaccines (VBIV) earnings report, listen to the earnings call, and analyze historical earnings performance with AI-powered insights.
Start investing in VBI Vaccines (VBIV)
Order type
Buy in
Order amount
Est. shares
0 shares
VBI Vaccines (VBIV) Earnings per Share (EPS) History
Signup for full accessBrowse free
VBI Vaccines (VBIV) Latest Earnings
The value each VBIV share was expected to gain vs. the value each share gained.
VBI Vaccines (VBIV) reported its most recent earnings on May 15, 2024 for Q1 2024, posting earnings per share (EPS) of -$0.55. This exceeded analysts' expectations of -$0.53 by 3.77%, marking a Miss.
For comparison, VBI Vaccines reported EPS of -$3.22 in the same quarter last year.
The company is expected to announce its next earnings report on 08/19/2025, with analysts projecting an EPS of $0.
VBI Vaccines (VBIV) Earnings History
Earnings | Est. EPS | Actual EPS | Surprise | |
---|---|---|---|---|
Q1 2025Aug 19, 2025 | – | Next earnings call Aug. 19, 2025 | ||
Q1 2024May 15, 2024 | -$0.53 | -$0.55 | +3.77% | |
Q4 2023Apr 16, 2024 | -$0.22 | -$0.01 | -95.45% | |
Q3 2023Nov 14, 2023 | -$0.14 | -$0.38 | +171.43% | |
Q2 2023Aug 14, 2023 | -$2.16 | -$2.17 | +0.46% | |
VBI Vaccines (VBIV) Earnings Related Price Changes
Earnings announcements may impact a stock’s price. This table highlights the VBI Vaccines’s price movement by comparing the day-before and day-after prices of recent earnings reports, along with the percentage change.
Report date | Price 1D before | Price 1D after | Change |
---|---|---|---|
May 15, 2024 | — | — | — |
Apr 16, 2024 | — | — | — |
Nov 14, 2023 | — | — | — |
Aug 14, 2023 | — | — | — |
VBI Vaccines (VBIV) Earnings FAQs
VBI Vaccines (VBIV) last reported earnings on May 15, 2024 for Q1 2024, posting an EPS of -$0.55, which Miss the estimate of -$0.53 by 3.77%.
For Q1 2024, VBI Vaccines (VBIV) reported an EPS of -$0.55, missing analysts' estimate of -$0.53 by 3.77%.
For Q1 2024, VBI Vaccines (VBIV) Miss expectations with an actual EPS of -$0.55 vs. an estimated EPS of -$0.53.
Following the last earnings report on May 15, 2024, VBI Vaccines (VBIV)'s stock price moved — from — to —.
The next VBI Vaccines (VBIV) earnings call is scheduled for Aug. 19, 2025, where executives will discuss financial results and outlook.